GLP-1 Impact For And On Employers
The Rise in Demand for GLP-1s Popularized for the weight-loss effects and usage by celebrities and pop culture icons, the interest in and demand for GLP-1 medications is on the rise.
GLP-1s come with hefty price tags that can burden plan sponsors and their members. Therefore, it’s imperative that these drugs are used appropriately.
John Tackman is a seasoned sales and strategic partnerships leader with over 15 years of experience in healthcare and pharmacy benefit management (PBM) space. He currently serves as Director of Strategic Partnership at MedOne Pharmacy Benefit Solutions, where he leads initiatives focused on complex clients, business development, client engagement, and educating employers on PBM. Throughout his career, John has focused his efforts on making pharmacy benefit management easier to understand and fighting for employers. Prior to joining MedOne, John held leadership roles at Archimedes, RxBenefits, Inc., and Anthem Inc, where he consistently delivered high-impact results across national accounts and helped shape strategic direction for growth and innovation.
John’s expertise spans strategic partnerships, healthcare management, product development, and analytics. He is known for his ability to articulate complex strategies, mentor teams, and drive process improvements that enhance client retention and brand positioning.
With a strong foundation in benefit marketing and insurance analytics, John brings a thoughtful, results-driven approach to every engagement. His passion for educating clients and consultants, combined with his robust communication skills, makes him a compelling speaker and trusted industry voice.
.png)
